Improvement of Gene-Edited Immune Cell Manufacturing for Clinical Trials

We are collaborating with multiple labs at UCSF to establish a gene-edited immune cell clinical platform
GIGIE001_Eyquem-Research-Feature-topic1

As immunotherapeutic strategies move toward more complex engineering and multiplexed editing, there is a growing need to optimize the manufacturing of CAR-engineered cells for the clinic. Our laboratory is focused on bolstering the efficiency of CAR T cell enrichment, improving the precision of T cell editing using novel tools developed in the lab. Finally, we are expanding our technologies to other immune cells and are optimizing gene editing protocols and CAR designs for NK cells.

Selected Publications

No data was found

Research Team

Jon Woo
Jon Woo

Institute Lab Manager

News

Media highlights of Pelka Lab's research.
Juggling Motherhood and Science
Read More >>
Cancer Immunologist Karin Pelka Joins Gladstone Institutes
Read More >>
Researchers discover immune cell “hubs” hiding in tumors
Read More >>
SU2C Peggy Prescott Early Career Scientist Award in Colorectal Cancer Research
Read More >>
Stand Up to Cancer Awards $1.1 Million in Grants to Research Teams
Read More >>
Faith Fight Finish Foundation Gala
Read More >>
‘Goodness, I’m getting emotional’: How Cowboys QB Dak Prescott brought Jerry Jones to tears at gala
Read More >>
Stand Up to Cancer Grants First Peggy Prescott Award in Colorectal Cancer Research
Read More >>